Suppr超能文献

用于纳米药物递送的微流体技术。

Microfluidics for Nanomedicine Delivery.

作者信息

Chen Kangfu, Yang Hongfen, Cai Ren

机构信息

Hunan Key Laboratory of Typical Environmental Pollution and Health Hazards, School of Public Health, Hengyang Medical School, University of South China, Hengyang 421001, China.

Department of Biomedical Engineering, Northwestern University, Chicago, Illinois 60611, United States.

出版信息

ACS Biomater Sci Eng. 2025 Feb 10;11(2):774-783. doi: 10.1021/acsbiomaterials.4c02052. Epub 2025 Jan 8.

Abstract

Nanomedicine is revolutionizing precision medicine, providing targeted, personalized treatment options. Lipid-based nanomedicines offer distinct benefits including high potency, targeted delivery, extended retention in the body, reduced toxicity, and lower required doses. These characteristics make lipid-based nanoparticles ideal for drug delivery in areas such as gene therapy, cancer treatment, and mRNA vaccines. However, traditional bulk synthesis methods for LNPs often produce larger particle sizes, significant polydispersity, and low encapsulation efficiency, which can reduce the therapeutic effectiveness. These issues primarily result from uneven mixing and limited control over particle formation during the synthesis. Microfluidic technology has emerged as a solution, providing precise control over particle size, uniformity, and encapsulation efficiency. In this mini review, we introduce the state-of-the-art microfluidic systems for lipid-based nanoparticle synthesis and functionalization. We include the working principles of different types of microfluidic systems, the use of microfluidic systems for LNP synthesis, cargo encapsulation, and nanomedicine delivery. In the end, we briefly discuss the clinical use of LNPs enabled by microfluidic devices.

摘要

纳米医学正在彻底改变精准医学,提供靶向、个性化的治疗选择。基于脂质的纳米药物具有显著优势,包括高效能、靶向递送、在体内的长时间留存、降低毒性以及较低的所需剂量。这些特性使基于脂质的纳米颗粒成为基因治疗、癌症治疗和mRNA疫苗等领域药物递送的理想选择。然而,传统的脂质纳米颗粒(LNP)批量合成方法通常会产生较大的粒径、显著的多分散性和较低的包封效率,这可能会降低治疗效果。这些问题主要源于合成过程中混合不均匀以及对颗粒形成的控制有限。微流控技术已成为一种解决方案,可对粒径、均匀性和包封效率进行精确控制。在本综述中,我们介绍了用于基于脂质的纳米颗粒合成和功能化的先进微流控系统。我们包括不同类型微流控系统的工作原理、微流控系统在LNP合成、货物包封和纳米药物递送中的应用。最后,我们简要讨论了微流控装置实现的LNP的临床应用。

相似文献

1
Microfluidics for Nanomedicine Delivery.
ACS Biomater Sci Eng. 2025 Feb 10;11(2):774-783. doi: 10.1021/acsbiomaterials.4c02052. Epub 2025 Jan 8.
2
Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
ACS Appl Mater Interfaces. 2020 Jul 29;12(30):34011-34020. doi: 10.1021/acsami.0c05489. Epub 2020 Jul 15.
3
Microfluidics: a transformational tool for nanomedicine development and production.
J Drug Target. 2016 Nov;24(9):821-835. doi: 10.1080/1061186X.2016.1198354. Epub 2016 Aug 5.
4
Microfluidics for Development of Lipid Nanoparticles: Paving the Way for Nucleic Acids to the Clinic.
ACS Appl Bio Mater. 2023 Sep 18;6(9):3566-3576. doi: 10.1021/acsabm.1c00732. Epub 2021 Sep 8.
7
The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution.
Mol Pharm. 2020 Mar 2;17(3):944-953. doi: 10.1021/acs.molpharmaceut.9b01182. Epub 2020 Feb 5.
8
Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems.
Adv Drug Deliv Rev. 2018 Mar 15;128:84-100. doi: 10.1016/j.addr.2018.03.008. Epub 2018 Mar 19.
9
Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications.
Expert Opin Drug Deliv. 2022 Oct;19(10):1381-1395. doi: 10.1080/17425247.2022.2135502. Epub 2022 Oct 20.
10
Microfluidics for the Production of Nanomedicines: Considerations for Polymer and Lipid-based Systems.
Pharm Nanotechnol. 2019;7(6):423-443. doi: 10.2174/2211738507666191019154815.

引用本文的文献

1
Emerging Trends in Microfluidic Biomaterials: From Functional Design to Applications.
J Funct Biomater. 2025 May 8;16(5):166. doi: 10.3390/jfb16050166.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验